-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*Only for medical professionals to read for reference, Professor Zhu Yao will show you the latest "Curious Hunting" research of JAMA Oncol
.
Why do some patients with localized prostate cancer "regret" after receiving treatment? For patients with localized prostate cancer, the guidelines recommended treatments include active monitoring, radical prostatectomy, and radiotherapy.
How to choose to make the patient “not regretful” as much as possible? Recently, JAMA Oncology, one of the top oncology journals, published an online report titled "The Relationship between Treatment Modality, Functional Outcomes, and Baseline Characteristics of Patients with Localized Prostate Cancer" (Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics).
With Treatment-Related Regret Among Men With Localized Prostate Cancer)
.
"Medical Oncology Channel" specially invited Professor Zhu Yao from the Cancer Hospital of Fudan University to share this research and interpret the results of the research from a clinical practical point of view, which is a "grounded gas" clinical dry goods for the majority of doctors and patients online
.
"Live long" or "live well"? The communication between doctors and patients before treatment needs to be more specific.
The medical community: Are there any patients with prostate cancer that you have contacted with similar conditions? How to effectively reduce the regret of patients after treatment? Professor Zhu Yao: In order to avoid the patient's regret after treatment, clinicians need to communicate fully with patients before treatment
.
Taking prostate cancer as an example, any treatment decision will greatly affect the rest of the patient's life
.
For metastatic malignant tumors, the treatment goals are mainly based on prolonging the survival of patients
.
Unlike metastatic malignant tumors, patients with localized prostate cancer can survive radiotherapy and surgery as long as 10-15 years
.
Based on this situation, clinicians must consider the possible long-term effects of treatment-related side effects on patients
.
Specifically, it needs to be comprehensively considered based on the patient's own physical fitness, personal preference for life functions, and the patient's interpretation of the pros and cons of treatment
.
Clinicians may face two major types of patients with malignant tumors: one of the core requirements is to live as much as possible; the other is willing to sacrifice part of the length of life in exchange for a better quality of life
.
The latter's willingness involves a more subtle issue, that is, some patients may be willing to sacrifice 10% of their lives in exchange for a 40%-50% improvement in quality of life; some patients may only be willing to sacrifice 5% of their lives
.
Therefore, clinicians need to fully understand the patient's treatment expectations and communicate with them around the possible side effects of treatment
.
This is also the "essence" of this study: patients must be fully involved in the process of treatment decision-making
.
Not only for cancer treatment, but also for pre-treatment communication needs to be "individualized" in the medical community: in clinical practice, there are often mismatches or mismatches in knowledge and concepts between doctors and patients, which increases the difficulty of communication between doctors and patients
.
How would you communicate with patients before making treatment decisions? Professor Zhu Yao: This research has given clinicians a lot of enlightenment
.
Considering the patient's own characteristics, if the patient has received higher education, or is too old, the effect of sexual function before and after treatment is relatively small, and the regret after treatment is relatively less
.
On the other hand, if patients have fewer side effects or complications after treatment, their regrets will be reduced accordingly
.
From this research, the lessons we can learn are: Clinicians need to make policies for people, not just for disease
.
For patients with no higher education, the "social support" mentioned in this study, such as support from families and other patients, is also very helpful in reducing patient regrets related to treatment
.
Through these supports, patients can understand the possible long-term side effects of treatment to a greater extent
.
For clinicians, minimizing damage to patients' normal functions and long-term complications can also significantly reduce patients' regrets related to treatment
.
How to improve the effectiveness of communication? The "multidisciplinary model" may have magical applications.
The medical community: What is the significance of this study for treatment decision-making for localized prostate cancer? Prof.
Zhu Yao: The focus of this research corresponds to the problem of medical satisfaction in clinical practice in China
.
It is not difficult to find that the less treatment-related regrets of patients, the higher the satisfaction of treatment
.
The evaluation of treatment efficacy is also multifaceted, including survival rate and quality of life
.
This study quantified the issue of treatment satisfaction
.
From this research, clinicians need to focus on learning the following three aspects: 1) The generation of treatment-related regrets reminds clinicians to continuously optimize clinical skills and treatment levels; 2) This research focuses on the patient’s overall personality, psychological characteristics and expectations for treatment.
This is precisely the part that China's clinical practice is relatively lacking
.
It also confirms from another angle that clinicians make medical decisions not just to focus on the disease itself; 3) As mentioned in the study, “surgery patients have more regrets after treatment, and radiotherapy patients have less regrets after treatment”, This also reminds clinicians that a multidisciplinary model should be introduced in the process of communicating and communicating with patients
.
Concentrating the process of communication and exchange on one platform may greatly reduce the regrets related to the treatment of patients
.
Experts comment that the long-term effects of essential treatments are comprehensively considered based on the patient's own physical fitness, personal preference for life functions, and the patient's interpretation of the pros and cons of the treatment
.
Patients must be fully involved in the process of treatment decision-making
.
The patient's own characteristics (higher education, older age, relatively small impact on sexual function before and after treatment), the regret after treatment is relatively less
.
Through the necessary social support, patients who have not received higher education can also understand to a greater extent the long-term side effects that the treatment may bring
.
In the process of carrying out clinical treatment, clinicians need to continuously optimize clinical skills and treatment levels, pay attention to the patient's overall personality, psychological characteristics and expectations for treatment, and introduce a multidisciplinary model
.
Expert profile Prof.
Yao Zhu, Chief Physician, Fudan University Cancer Hospital, Doctoral Supervisor, Deputy Director of Urology, Fudan University Cancer Hospital, Secretary General of Prostate Cancer Expert Committee, Chinese Society of Clinical Oncology, Deputy Director, Shanghai Anti-Cancer Association Youth Council, Fudan, 2019 University Youth May 4th Medal Winners of the Shanghai Municipal Health Commission’s Young May 4th Medal were selected for the 2018 Shanghai “Medical Rising Star” Outstanding Young Medical Talents were selected for the 7th Fudan University’s Top Ten Young Medical Careers selected for the third batch of Fudan University’s Talent Program Selected as the editorial board member of Prostate Cancer and Prostatic Disease in the 2015 Shanghai Youth Science and Technology Venus Program.
The National Natural Science Review Expert won the first prize of Shanghai Science and Technology Progress Award as the second complete person.
Representative papers were published in European Urology and Clinical Cancer Research.
Magazine references: [1]Wallis Christopher JD,Zhao Zhiguo,Huang Li-Ching et al.
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
[J] .
JAMA Oncol , 2021.
.
Why do some patients with localized prostate cancer "regret" after receiving treatment? For patients with localized prostate cancer, the guidelines recommended treatments include active monitoring, radical prostatectomy, and radiotherapy.
How to choose to make the patient “not regretful” as much as possible? Recently, JAMA Oncology, one of the top oncology journals, published an online report titled "The Relationship between Treatment Modality, Functional Outcomes, and Baseline Characteristics of Patients with Localized Prostate Cancer" (Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics).
With Treatment-Related Regret Among Men With Localized Prostate Cancer)
.
"Medical Oncology Channel" specially invited Professor Zhu Yao from the Cancer Hospital of Fudan University to share this research and interpret the results of the research from a clinical practical point of view, which is a "grounded gas" clinical dry goods for the majority of doctors and patients online
.
"Live long" or "live well"? The communication between doctors and patients before treatment needs to be more specific.
The medical community: Are there any patients with prostate cancer that you have contacted with similar conditions? How to effectively reduce the regret of patients after treatment? Professor Zhu Yao: In order to avoid the patient's regret after treatment, clinicians need to communicate fully with patients before treatment
.
Taking prostate cancer as an example, any treatment decision will greatly affect the rest of the patient's life
.
For metastatic malignant tumors, the treatment goals are mainly based on prolonging the survival of patients
.
Unlike metastatic malignant tumors, patients with localized prostate cancer can survive radiotherapy and surgery as long as 10-15 years
.
Based on this situation, clinicians must consider the possible long-term effects of treatment-related side effects on patients
.
Specifically, it needs to be comprehensively considered based on the patient's own physical fitness, personal preference for life functions, and the patient's interpretation of the pros and cons of treatment
.
Clinicians may face two major types of patients with malignant tumors: one of the core requirements is to live as much as possible; the other is willing to sacrifice part of the length of life in exchange for a better quality of life
.
The latter's willingness involves a more subtle issue, that is, some patients may be willing to sacrifice 10% of their lives in exchange for a 40%-50% improvement in quality of life; some patients may only be willing to sacrifice 5% of their lives
.
Therefore, clinicians need to fully understand the patient's treatment expectations and communicate with them around the possible side effects of treatment
.
This is also the "essence" of this study: patients must be fully involved in the process of treatment decision-making
.
Not only for cancer treatment, but also for pre-treatment communication needs to be "individualized" in the medical community: in clinical practice, there are often mismatches or mismatches in knowledge and concepts between doctors and patients, which increases the difficulty of communication between doctors and patients
.
How would you communicate with patients before making treatment decisions? Professor Zhu Yao: This research has given clinicians a lot of enlightenment
.
Considering the patient's own characteristics, if the patient has received higher education, or is too old, the effect of sexual function before and after treatment is relatively small, and the regret after treatment is relatively less
.
On the other hand, if patients have fewer side effects or complications after treatment, their regrets will be reduced accordingly
.
From this research, the lessons we can learn are: Clinicians need to make policies for people, not just for disease
.
For patients with no higher education, the "social support" mentioned in this study, such as support from families and other patients, is also very helpful in reducing patient regrets related to treatment
.
Through these supports, patients can understand the possible long-term side effects of treatment to a greater extent
.
For clinicians, minimizing damage to patients' normal functions and long-term complications can also significantly reduce patients' regrets related to treatment
.
How to improve the effectiveness of communication? The "multidisciplinary model" may have magical applications.
The medical community: What is the significance of this study for treatment decision-making for localized prostate cancer? Prof.
Zhu Yao: The focus of this research corresponds to the problem of medical satisfaction in clinical practice in China
.
It is not difficult to find that the less treatment-related regrets of patients, the higher the satisfaction of treatment
.
The evaluation of treatment efficacy is also multifaceted, including survival rate and quality of life
.
This study quantified the issue of treatment satisfaction
.
From this research, clinicians need to focus on learning the following three aspects: 1) The generation of treatment-related regrets reminds clinicians to continuously optimize clinical skills and treatment levels; 2) This research focuses on the patient’s overall personality, psychological characteristics and expectations for treatment.
This is precisely the part that China's clinical practice is relatively lacking
.
It also confirms from another angle that clinicians make medical decisions not just to focus on the disease itself; 3) As mentioned in the study, “surgery patients have more regrets after treatment, and radiotherapy patients have less regrets after treatment”, This also reminds clinicians that a multidisciplinary model should be introduced in the process of communicating and communicating with patients
.
Concentrating the process of communication and exchange on one platform may greatly reduce the regrets related to the treatment of patients
.
Experts comment that the long-term effects of essential treatments are comprehensively considered based on the patient's own physical fitness, personal preference for life functions, and the patient's interpretation of the pros and cons of the treatment
.
Patients must be fully involved in the process of treatment decision-making
.
The patient's own characteristics (higher education, older age, relatively small impact on sexual function before and after treatment), the regret after treatment is relatively less
.
Through the necessary social support, patients who have not received higher education can also understand to a greater extent the long-term side effects that the treatment may bring
.
In the process of carrying out clinical treatment, clinicians need to continuously optimize clinical skills and treatment levels, pay attention to the patient's overall personality, psychological characteristics and expectations for treatment, and introduce a multidisciplinary model
.
Expert profile Prof.
Yao Zhu, Chief Physician, Fudan University Cancer Hospital, Doctoral Supervisor, Deputy Director of Urology, Fudan University Cancer Hospital, Secretary General of Prostate Cancer Expert Committee, Chinese Society of Clinical Oncology, Deputy Director, Shanghai Anti-Cancer Association Youth Council, Fudan, 2019 University Youth May 4th Medal Winners of the Shanghai Municipal Health Commission’s Young May 4th Medal were selected for the 2018 Shanghai “Medical Rising Star” Outstanding Young Medical Talents were selected for the 7th Fudan University’s Top Ten Young Medical Careers selected for the third batch of Fudan University’s Talent Program Selected as the editorial board member of Prostate Cancer and Prostatic Disease in the 2015 Shanghai Youth Science and Technology Venus Program.
The National Natural Science Review Expert won the first prize of Shanghai Science and Technology Progress Award as the second complete person.
Representative papers were published in European Urology and Clinical Cancer Research.
Magazine references: [1]Wallis Christopher JD,Zhao Zhiguo,Huang Li-Ching et al.
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
[J] .
JAMA Oncol , 2021.
